Stockreport

Pelthos Therapeutics to Report Third Quarter 2025 Financial Results on November 13, 2025

Pelthos Therapeutics Inc.  (PTHS) 
PDF DURHAM, N.C., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company committed to commercializing innovative th [Read more]